Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH
Clinical trial NCT05569655 · UNKNOWN
Trial details
- NCT number
- NCT05569655
- Sponsor
- Chinese Pulmonary Vascular Disease Research Group
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-06
- Primary completion
- 2022-11-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.